Research / Stocks / XPER XPER NYSE CIK 0001788999
Xperi Inc. · Services-Prepackaged Software
COVERAGE / STANDARD
Latest filing 8-K · Aug 7, 2026
Research state Latest filing analysis is current
Last SEC check Sep 13, 2026
Data basis Official SEC · no quote feed Component status Filing Evidence Research Current Official SEC filing history is available
Structured Financials Research Current Validated structured financial research is available
Filing Analysis Research Current No filing analysis job is currently running
Fundamental State Research Current Fundamental State depends on validated comparable financial metrics
RESEARCH SNAPSHOT Xperi Inc.'s latest supported as-filed period reports revenue of $114.5M , 8.1% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
Deterministic / evidence backed Key research observations No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Current configuration / point in time Fundamental state A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Debt relative to revenue 56th Own-history percentile · N=9
Method Level · gp.fundamentals.debt_to_revenue
Raw value 24.17% · OPTIONAL
Capex intensity 7th Own-history percentile · N=14
Method Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.43% · OPTIONAL
Operating cash generation 93th Own-history percentile · N=14
Method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 12.72% · OPTIONAL
Revenue growth 100th Own-history percentile · N=11
Method Yoy · gp.fundamentals.revenue
Raw value 8.08% · CORE
Operating margin 100th Own-history percentile · N=15
Method Level · gp.fundamentals.operating_margin
Raw value 2.54% · CORE
R&D intensity 0th Own-history percentile · N=15
Method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 19.05% · OPTIONAL
SBC intensity 0th Own-history percentile · N=15
Method Level · gp.fundamentals.sbc_revenue_ratio
Deterministic multi-period research Company direction Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
As filed Jun 30, 2026 General Corporate
Capital Allocation 5 evidence-backed dimensions Balance Sheet Leverage Inflecting Capex Intensity Inflecting Cash Generation Stable R And D Intensity Decreasing Sbc Intensity Improving [email protected] · 12 historical states · 38% confidenceCompany Direction 7 evidence-backed dimensions Capex Intensity Inflecting Cash Generation Stable Growth Inflecting Profitability Improving R And D Intensity Decreasing [email protected] · 12 historical states · 38% confidenceFinancial Quality 4 evidence-backed dimensions Balance Sheet Leverage Inflecting Cash Generation Stable Profitability Improving Sbc Intensity Improving [email protected] · 12 historical states · 38% confidenceGovernance Evidence 3 evidence-backed dimensions Filing Amendments None Detected Auditor Changes None Detected Sbc Intensity Observed [email protected] · 12 historical states · 50% confidenceInterpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Comparable evidence Peer context Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
Sbc Intensity
XPER 6.0
Peer median 10.9
Peer percentile 27th 142 valid peers · 90% coverage · -0.6 robust σ Capex Intensity
XPER 0.4
Peer median 1.0
Peer percentile 28th 124 valid peers · 79% coverage · -0.4 robust σ R And D Intensity
XPER 19.0
Peer median 21.6
Peer percentile 37th 131 valid peers · 83% coverage · -0.2 robust σ Profitability
XPER 2.5
Peer median -1.8
Peer percentile 56th 148 valid peers · 94% coverage · +0.2 robust σ Growth
XPER 8.1
Peer median 10.7
Peer percentile 38th 129 valid peers · 82% coverage · -0.2 robust σ Cash Generation
XPER 12.7
Peer median 16.4
Peer percentile 42th 143 valid peers · 91% coverage · -0.2 robust σ Open group breadth → Divergence is context, not positive or negative. Flagship analysis / V3 What changed? The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q 0001788999-26-000018 9 governed changes · top 7 shown
01
INFORMATIONAL IMPORTANCE Cash 0TH HISTORICAL PCTL · N=3
Cash & equivalents decreased 4.8% Cash & equivalents changed -4.8% from the comparable as-filed period.
Why this ranks here · [email protected] $95.1M → $90.6M Comparable → current
02
LOW IMPORTANCE Debt 100TH HISTORICAL PCTL · N=5
Debt unchangedd 0.0% Debt changed +0.0% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes.
Why this ranks here · [email protected] $27.7M → $27.7M Comparable → current
03
HIGH IMPORTANCE Net Income 67TH HISTORICAL PCTL · N=3
Net income increased 89.9% Net income changed +89.9% from the comparable as-filed period.
Why this ranks here · [email protected] -$14.8M → -$1.5M Comparable → current
04
HIGH IMPORTANCE Operating Income 100TH HISTORICAL PCTL · N=3
Operating income increased 126.2% As-filed financials Financial trajectory Each point keeps the date investors could first observe it and its accession.
As filed Current normalized · later
Capex / revenue 0.43% -55.1% ↓ Capital expenditure $497,000 -55.0% ↓ Cash & equivalents $90.6M +0.0% ↑ Debt $27.7M +0.0% ↑ Free-cash-flow proxy $14.1M +173.6% ↑ Interest expense $684,000 +0.9% ↑ Inventory $6.7M -26.5% ↓ Net income -$1.5M +80.8% ↑
ACTIVE TRACE Revenue XPER · as filed with the SEC · reported-date aware
Capex / revenue Q2 / 2026-06-30 0.43% -55.1% sequential point Trace ↗ Evidence inspector
Loading lineage… × Capital expenditure Q2 / 2026-06-30 $497,000 -55.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Cash & equivalents Q2 / 2026-06-30 $90.6M +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Debt Q2 / 2026-06-30 $27.7M +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Free-cash-flow proxy Q2 / 2026-06-30 $14.1M +173.6% sequential point Trace ↗ Evidence inspector
Loading lineage… × Interest expense Q2 / 2026-06-30 $684,000 +0.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Inventory FY / 2022-12-31 $6.7M -26.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Net income Q2 / 2026-06-30 -$1.5M +80.8% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating cash flow Q2 / 2026-06-30 $14.6M +180.8% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating margin Q2 / 2026-06-30 2.54% +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Research & development Q2 / 2026-06-30 $21.8M -19.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Revenue Q2 / 2026-06-30 $114.5M +0.3% sequential point Trace ↗ Evidence inspector
Loading lineage… × Primary evidence Filing timeline Direct SEC links, filing dates, report periods, and amendment flags.
8-K Aug 7, 2026 Period Aug 6, 2026 0001788999-26-000020SEC ↗ 10-Q Aug 6, 2026 Period Jun 30, 2026 0001788999-26-000018SEC ↗ 8-K Aug 5, 2026 Period Aug 5, 2026 0001788999-26-000015SEC ↗ 10-Q May 7, 2026 Period Mar 31, 2026 0001788999-26-000013SEC ↗ 8-K May 6, 2026 Period May 6, 2026 0001788999-26-000010SEC ↗ 4 Apr 21, 2026 Period Apr 17, 2026 0001104659-26-046052SEC ↗ 4 Apr 21, 2026 Period Apr 17, 2026 0001104659-26-046051SEC ↗ Form 4 Insider activity Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
“Insider purchase” rule Code P · non-derivative · acquired · direct ownership · positive price and shares · not amended
Inspectable by design
Every displayed number has a lineage. GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗